Traws Pharma Ownership | Who Owns Traws Pharma?


OverviewRevenueFinancialsChartTranscripts

Traws Pharma Ownership Summary


Traws Pharma is owned by 2.42% institutional investors, 10.46% insiders, and 87.12% retail investors. Adage capital partners gp is the largest institutional shareholder, holding 8.87% of TRAW shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.36% of its assets in Traws Pharma shares.

TRAW Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockTraws Pharma2.42%10.46%87.12%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Adage capital partners gp730.00K8.87%$1.34M
Ikarian capital678.14K8.24%$1.24M
Orbimed advisors605.53K7.36%$1.11M
Dauntless investment group417.00K5.07%$763.11K
Vestal point capital, lp150.00K2.58%$277.50K
Boothbay fund management194.54K2.36%$356.00K
Vanguard group87.26K1.50%$98.60K
Geode capital management77.10K0.94%$141.10K
Palumbo wealth management61.17K0.74%$111.95K
Vanguard fiduciary trust31.80K0.39%$58.20K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Dauntless investment group417.00K0.51%$763.11K
Ikarian capital678.14K0.10%$1.24M
Palumbo wealth management61.17K0.03%$111.95K
Orbimed advisors605.53K0.02%$1.11M
Vestal point capital, lp150.00K0.01%$277.50K
Boothbay fund management194.54K0.00%$356.00K
Lynx1 capital management lp15.08K0.00%$27.59K
Adage capital partners gp730.00K0.00%$1.34M
Tower research capital llc (trc)3.96K0.00%$7.25K
Vermillion & white wealth management group96.000.00%$142.00

Top Buyers

HolderShares% AssetsChange
Dauntless investment group417.00K0.51%417.00K
Palumbo wealth management61.17K0.03%61.17K
Vanguard fiduciary trust31.80K-31.80K
Jane street group21.24K-21.24K
Geode capital management77.10K-15.45K

Top Sellers

HolderShares% AssetsChange
Alyeska investment group---52.63K
Xtx topco---42.21K
Citadel advisors---24.82K
Two sigma securities---17.17K
Susquehanna group, llp---14.20K

New Positions

HolderShares% AssetsChangeValue
Dauntless investment group417.00K0.51%417.00K$763.11K
Palumbo wealth management61.17K0.03%61.17K$111.95K
Vanguard fiduciary trust31.80K-31.80K$58.20K
Jane street group21.24K-21.24K$38.87K
Lynx1 capital management lp15.08K0.00%15.08K$27.59K

Sold Out

HolderChange
Citigroup-1.00
Assetmark-2.00
Advisor group-8.00
Raymond james financial-102.00
Hrt financial lp-12.57K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202612-42.86%198,905-94.18%20.07%9-35.71%2-
Dec 31, 20257-61.11%192,555-85.24%30.66%3-66.67%1-
Sep 30, 202517-10.53%1,304,4993.25%224.76%950.00%1-80.00%
Jun 30, 202519-1,263,487-27.06%2146.34%6-50.00%525.00%
Mar 31, 2025195.56%1,732,32748.01%632.01%12-4100.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr55.19K0.36%-
Blackrock Extended Mkt Fund CF50.34K0.33%-
Fidelity Extended Market Index46.61K0.31%5.56K
Spartan Extended Market Index Pool F9.90K0.07%5.13K
Fidelity Series Total Market Index8.10K0.05%-
Fidelity Total Market Index7.47K0.05%-
Spartan Total Market Index Pool G4.28K0.03%-
Extended Equity Market Fund B1.94K0.01%-
Extended Equity Market Fund E1.94K0.01%-
BlackRock Extended Equity Market Fund K1.65K0.01%-12.00

Recent Insider Transactions


DateNameRoleActivityValue
Apr 16, 2026ORBIMED ADVISORS LLC-Buy$1.00M
Apr 16, 2026ORBIMED ADVISORS LLC-Buy$1.00M
Apr 16, 2026ORBIMED ADVISORS LLC-Buy$998.21K
Apr 16, 2026ORBIMED ADVISORS LLC-Buy$3.00M
Dec 29, 2024ORBIMED ADVISORS LLC-Buy$963.48

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q4--
2025 Q2--
2025 Q1--
2024 Q48-

TRAW Ownership FAQ


Who Owns Traws Pharma?

Traws Pharma shareholders are primarily institutional investors at 2.42%, followed by 10.46% insiders and 87.12% retail investors. The average institutional ownership in Traws Pharma's industry, Biotech Stocks , is 35.75%, which Traws Pharma falls below.

Who owns the most shares of Traws Pharma?

Traws Pharma’s largest shareholders are Adage capital partners gp (730K shares, 8.87%), Ikarian capital (678.14K shares, 8.24%), and Orbimed advisors (605.53K shares, 7.36%). Together, they hold 24.47% of Traws Pharma’s total shares outstanding.

Does Blackrock own Traws Pharma?

BlackRock is not among the top 10 institutional shareholders of Traws Pharma.

Who is Traws Pharma’s biggest shareholder by percentage of total assets invested?

Dauntless investment group is Traws Pharma’s biggest shareholder by percentage of total assets invested, with 0.51% of its assets in 417K Traws Pharma shares, valued at 763.11K$.

Who is the top mutual fund holder of Traws Pharma shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Traws Pharma shares, with 0.36% of its total shares outstanding invested in 55.19K Traws Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools